NCT07383506 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07383506
Title	A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Cogent Biosciences, Inc.
Indications	Her2-receptor negative breast cancer endometrial cancer female reproductive organ cancer colorectal cancer Advanced Solid Tumor breast cancer head and neck cancer
Therapies	CGT6297
Age Groups:	senior \| adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
NEXT Austin		Austin	Texas	78758	United States	Details
NEXT Virginia		Fairfax	Virginia	22031	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07383506Clinical Trial Detail